Bio Place

Latest Medical, Biological, and Genomic News!


Myocarditis 2-3 times higher after 2nd dose of Moderna's vaccine than Pfizer's

The "risk of myocarditis is two to three times higher after a second dose of Moderna's Spikevax compared with Pfizer and BioNTech’s Comirnaty. Cases of myocarditis...were most prevalent in men under 40 years of age."
Fierce Pharma
2022-11-22 06:05:29